Biliary Cancers: EGFR INhibitor, Gemcitabine and Oxaliplatin

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2007
A Multicenter, Randomized Phase II Trial Assessing the Activity of Gemcitabine - Oxaliplatin Chemotherapy Alone or in Combination with Cetuximab in Patients with Advanced Biliary Cancer.
Epistemonikos ID: 57706da3ad529ce051d54318fe27226b2dd12473
First added on: Apr 13, 2018